Across TCGA cell cohorts, CT47A9 protein abundance is significantly associated with the drug of many other genes, with 65 significant associations in total. CNS shows the largest number of these associations.

The most reproducible CT47A9-associated genes across cancer lineages are Vorinostat, Niraparib, and N23918-95-7. Each is linked with CT47A9 in more than 1 cancer types. Because this analysis shows association rather than direction, both CT47A9-to-partner and partner-to-CT47A9 results are reported.

Each partner links to its own Q-omics profile.

protein abundance associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CT47A9→partner) and Y-score (partner→CT47A9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
CNS	Vorinostat →	+0.423	+2.783	.046	.047	3	1
CNS	Niraparib →	+1.285	+4.075	.018	.019	3	1
CNS	N23918-95-7 →	+0.484	+4.075	.008	.019	3	1
CNS	Etoposide →	+2.336	+2.783	.003	.047	3	1
CNS	ZL109 →	+0.606	+2.783	<.001	.047	3	1
CNS	Doxorubicin →	+1.120	+4.075	.026	.019	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 65 associations by consensus.

Exploration

CT47A9 survival (RNA) · tumor vs normal (RNA) · all CT47A9 data types